Caricamento...
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
Apixaban is an oral, direct factor Xa inhibitor that inhibits both free and clot-bound factor Xa, and has been approved for clinical use in several thromboembolic disorders, including reduction of stroke risk in non-valvular atrial fibrillation, thromboprophylaxis following hip or knee replacement s...
Salvato in:
| Pubblicato in: | Clin Pharmacokinet |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer International Publishing
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6769096/ https://ncbi.nlm.nih.gov/pubmed/31089975 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-019-00775-z |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|